The Immunogenicity and Safety of COVID-19 and Influenza Vaccine Co-administration and Interval in Immunocompromised Hosts

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06599658

Title field or adapter rule

{'original_value': 'The Immunogenicity and Safety of COVID-19 and Influenza Vaccine Co-administration and Interval in Immunocompromised Hosts', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.024841+00:00

Published At

2026-10-26T00:00:00+00:00

Record Updated At

2026-10-26

Source Retrieved At

2026-10-31T22:18:41.628690+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["COVID 19", "Influenza", "Rheumatoid Arthritis (RA)", "Systemic Lupus Erthematosus", "Inflammatory Bowel Disease", "Solid Organ Transplant Recipients", "Immunocompromised Host", "People Living With HIV"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-26", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06599658"

protocolSection.identificationModule.officialTitle

"The Immunogenicity and Safety of COVID-19 and Influenza Vaccine Co-administration and Interval in Immunocompromised Hosts"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• COVID 19 (protocolSection.conditionsModule.conditions)
• Influenza (protocolSection.conditionsModule.conditions)
• Rheumatoid Arthritis (RA) (protocolSection.conditionsModule.conditions)
• Systemic Lupus Erthematosus (protocolSection.conditionsModule.conditions)
• Inflammatory Bowel Disease (protocolSection.conditionsModule.conditions)
• Solid Organ Transplant Recipients (protocolSection.conditionsModule.conditions)
• Immunocompromised Host (protocolSection.conditionsModule.conditions)
• People Living With HIV (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Group 1', 'Group 3'], 'description': 'National Advisory Committee on Immunization (NACI) recommended seasonal inactivated influenza vaccine for moderate to severely immunocompromised patients by age at baseline', 'name': 'Inactivated influenza vaccine (IIV) at baseline', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Group 1', 'Group 2'], 'description': 'Updated NACI recommended COVID-19 booster for moderate to severely immunocompromised patients at a 3-month interval', 'name': 'COVID-19 Vaccines at a 3-month interval', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Group 2', 'Group 4'], 'description': 'National Advisory Committee on Immunization (NACI) recommended seasonal inactivated influenza vaccine for moderate to severely immunocompromised patients by age 1-month following initial COVID-19 booster', 'name': 'Inactivated influenza vaccine at Month 1', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Group 3', 'Group 4'], 'description': 'Updated NACI recommended COVID-19 booster for moderate to severely immunocompromised patients at a 6-month interval', 'name': 'COVID-19 Vaccines at a 6-month interval', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.